Effect of Plant Based High Energy High Protein Oral Nutritional Supplement on Nutritional Intake in Patients With or at Risk of Disease Related Malnutrition.
PRO-PLANT
PRO-PLANT
Sponsor study identifier
interventional
76
2 countries
2
Study Start
March 17, 2025
Actual (reported)Primary Completion
September 8, 2026
Actual (reported)Study Completion
September 8, 2026
Actual (reported)The subjects will use study product twice daily for 8 weeks starting at Visit 1. The recommendation is to consume one serving in the morning and one in the afternoon / evening between meals. The duration of the study for each subject will be approximately 11 weeks, comprising a screening period of max 2 weeks, an intervention period of 8 weeks, and a follow up phone call 1 week after completion of the intervention. A blood sample will be drawn at visit 1 and visit 3.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 8, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 6, 2025
Actual (reported)January 17, 2025
Actual (reported)March 17, 2025
Actual (reported)September 8, 2026
Actual (reported)September 8, 2026
Actual (reported)To investigate the effect of PB HEHP ONS compared to DB HEHP ONS on nutritional intake (energy & protein) in subjects with or at risk of Disease Related Malnutrition (DRM) and/or prescribed with ONS.
Mean total protein intake and mean total energy intake in subject with or at risk of Disease Related malnutrition (DRM) and/or prescribed with ONS will be measured by 3-day nutritional intake diary at baseline, at week 4 and week 8.
11 weeks
Test Product
Control Product
Plant based high energy high protein ONS 2 servings/day for a period of 8 weeks.
Dairy based high energy high protein ONS 2 servings equivalent in energy \& protein for a period of 8 weeks.
Meclinas
Mechelen, 2800, Belgium
QClinical
Rotterdam, Netherlands
76 participants (actual enrollment reported by the registry).
First Submitted
January 6, 2025
First Posted
January 17, 2025
Study Start
March 17, 2025
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
September 8, 2026
Actual (reported)Study Completion
September 8, 2026
Actual (reported)Last Updated
October 8, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: